VANTAGEPOINT INVESTMENT ADVISERS LLCVANTAGEPOINT INVESTMENT ADVISERS LLC

Institutional investor · Portfolio as of Q3 2022

Top Holdings10 positions

Checking export access…
Activity:
IVVIVV
ETF

iShares Trust CORE S&P500 ETF

449,460$161.2M29.4%$367.41-7.59%
10 qtrssince 2020-Q2
Decreased
0
AGGAGG
ETF

ISHARES TR

1.1M$101.6M18.5%$96.02-12.81%
10 qtrssince 2020-Q2
Increased
72
IWFIWF
ETF

iShares Trust RUS 1000 GRW ETF

448,300$94.3M17.2%$209.990.00%
1 qtr
New
95
TLTTLT
ETF

ISHARES TR

703,235$72M13.1%$95.82-8.34%
2 qtrssince 2022-Q2
Increased
74
VUGVUG
ETF

Vanguard Index Funds MORNINGSTAR GROWTH ETF

231,800$49.6M9.0%$34.900.00%
1 qtr
New
93
282,350$21.1M3.8%——
2 qtrssince 2022-Q2
Decreased
0
VCSHVCSH
ETF

VANGUARD SHORT-TERM CORPORATE BOND ETF

278,410$20.7M3.8%$65.38-2.11%
2 qtrssince 2022-Q2
Decreased
0
IGSBIGSB
ETF

ISHARES 1-5 YEAR INVESTMENT GRADE CORPORATE BOND ETF

219,740$10.8M2.0%$43.14-2.02%
2 qtrssince 2022-Q2
Decreased
0
VTVVTV
ETF

VANGUARD INDEX FDS

78,100$9.6M1.8%$119.29-5.74%
2 qtrssince 2022-Q2
Decreased
0
IWDIWD
ETF

ISHARES RUSSELL 1000 VALUE ETF

56,300$7.7M1.4%$135.92-5.22%
2 qtrssince 2022-Q2
Decreased
0
$548.7M
AUM
10
Positions
Q3 2022
Filing
HI score · 1.0/5
Quarterly 13F Value Change
Not enough history yet
Activity profile
$ moved · Q3'22
New38%Increased5%Decreased40%Exited16%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.4 quarters
<1Q20%1-4Q50%1-2Y0%2Y+30%

VANTAGEPOINT INVESTMENT ADVISERS LLC manages $548.7M across 10 positions as of Q3 2022. Top holdings: IVV (29.4%), AGG (18.5%), IWF (17.2%). Fund DNA: Steady Compounder. HoldingsIntel Score: 1/5.0.

Q3 2022 Summary

Added 2 new positions, exited 1, increased 2, trimmed 6. Top move: IWF (NEW, conviction 95). Portfolio: $549M across 10 positions.

Top holdings by portfolio weight

Total AUM$549M
IVV29.38%
AGG18.52%
IWF17.19%
TLT13.13%
VUG9.04%
VANGUARD SHO3.85%
VCSH3.77%
IGSB1.97%
VTV1.76%
IWD1.40%

Portfolio allocation by GICS sector

Sectors1
Unknown100.00%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Unknown
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Weak(1.0 / 5.0)
Holdings P&L84
Conviction49
Concentration51
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Top Losers

Checking access…

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
4Q
VUGVUGVanguard Index Funds MORNINGSTAR GROWTH ETF
Q3 2025 → Q2 2026+6.8M shares+$581.2M
3Q
AVEMAVEMAVANTIS EMERGING MARKETS EQUITY ETF
Q4 2025 → Q2 2026+126,777 shares+$60.7M
2Q
VWOVWOVanguard International Equity Index Funds FTSE EMR MKT ETF
Q1 2026 → Q2 2026+521,392 shares+$44.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used